Gennex Laboratories Ltd
17 Nov 2026 12:00 AM
Gennex Laboratories Ltd consolidated sales up 6.07% on year in Q2FY2027, net profit saw a mild growth of 4.28%,
Gennex Laboratories Ltd`s net profit inched up 4.28% to Rs 4.87 crore, while revenue from operations slightly gained 6.07% to Rs 42.26 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.72 lakh crore, rising 6.98%. It has slipped by 2.03% over last one week and gained upto 4.96% in last one month while the market capitalization of Gennex Laboratories Ltd has improved by 1.23% and 22.94% in the same period respectively.
Profit before tax (PBT) of Gennex Laboratories Ltd stood at Rs 5.13 crore in Q2 FY27, nosediving by 15.35% year-on-year, and easing 4.27% quarter-on-quarter. EBITDA came in at Rs 4 crore, crashing by 53.57% YoY and jumping 48.10% sequentially.
Total expenses grew marginally by 5.53% to Rs 38.37 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 34.95 crore, going up by 17.80% YoY, while employee benefits expense was at Rs 2.45 crore, witnessing a strong rise of 23.74% YoY.
For FY26, revenue from operations witnessed a strong growth of 25.26% to Rs 172.74 crore, while net profit registered a growth of 15.78% to Rs 20.98 crore, compared to previous FY. EBITDA witnessed a strong improvement of 595% to Rs 14.19 crore, and PBT saw a minor gain of 8.60% to Rs 23.24 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 63.65 crore in FY26, as against Rs 10.8 crore in FY25.
Gennex Laboratories Ltd crashed 39.57% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.35% during the same period.
Gennex Laboratories Ltd
16 Nov 2026 12:00 AM
Gennex Laboratories Ltd consolidated sales up 6.07% on year in Q2FY2027, net profit grew slightly 4.28%,
Gennex Laboratories Ltd`s net profit saw a mild growth of 4.28% to Rs 4.87 crore, while revenue from operations slightly gained 6.07% to Rs 42.26 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.76 lakh crore, gaining 6.97%. It has softened by 0.66% over last one week and gained upto 6.26% in last one month while the market capitalization of Gennex Laboratories Ltd has improved by 5.58% and 21.17% in the same period respectively.
Profit before tax (PBT) of Gennex Laboratories Ltd stood at Rs 5.13 crore in Q2 FY27, tanking 15.35% year-on-year, and easing 4.27% quarter-on-quarter. EBITDA came in at Rs 4 crore, tumbling by 53.57% YoY and jumping 48.10% sequentially.
Total expenses grew marginally by 5.53% to Rs 38.37 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 34.95 crore, increasing 17.80% YoY, while employee benefits expense was at Rs 2.45 crore, surging 23.74% YoY.
For FY26, revenue from operations witnessed a strong growth of 25.26% to Rs 172.74 crore, while net profit registered a growth of 15.78% to Rs 20.98 crore, compared to previous FY. EBITDA jumped by 595% to Rs 14.19 crore, and PBT inched up 8.60% to Rs 23.24 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 63.65 crore in FY26, as against Rs 10.8 crore in FY25.
Gennex Laboratories Ltd plunged by 39.63% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.42% during the same period.
Gennex Laboratories Ltd
30 Jul 2026 12:00 AM
Gennex Laboratories to declare Quarterly Results,
Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 August 2026.
Gennex Laboratories Ltd
01 Jun 2026 12:00 AM
Gennex Laboratories consolidated net profit rises 61.21% in the March 2026 quarter,
Net profit of Gennex Laboratories rose 61.21% to Rs 3.74 crore in the quarter ended March 2026 as against Rs 2.32 crore during the previous quarter ended March 2025. Sales rose 51.15% to Rs 60.96 crore in the quarter ended March 2026 as against Rs 40.33 crore during the previous quarter ended March 2025.For the full year,net profit rose 14.52% to Rs 18.46 crore in the year ended March 2026 as against Rs 16.12 crore during the previous year ended March 2025. Sales rose 25.26% to Rs 172.74 crore in the year ended March 2026 as against Rs 137.90 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales60.9640.33 51 172.74137.90 25 OPM %9.655.01 -12.9819.69 - PBDT6.134.65 32 26.4923.54 13 PBT4.974.10 21 23.8421.55 11 NP3.742.32 61 18.4616.12 15 Powered by Capital Market - Live News
Gennex Laboratories Ltd
20 May 2026 12:00 AM
Gennex Laboratories to discuss results,
Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2026.
Subscribe for our
newsletter
newsletter
HSL Mobile App